SIMARD JOHN (Chief Executive Officer) sold 2.3% of their position (89.29K shares) of XBIOTECH INC. on the open market
Open‑market sale worth $1.13M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 10/15/2021ACC: 0001209191-21-060523
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
-89.29K
Net shares
Net seller
$1.13M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
89.29K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−39.29K
Price / share
$12.45
Trade value
$489.11K
% of position
1.0%
10/7/2021
3.96M→3.92M
Common Stock
Direct
Shares
−18K
Price / share
$12.77
Trade value
$229.94K
% of position
0.5%
10/12/2021
3.99M→3.97M
Common Stock
Direct
Shares
−10.88K
Price / share
$12.83
Trade value
$139.53K
% of position
0.3%
10/13/2021
3.97M→3.96M
Common Stock
Direct
Shares
−21.13K
Price / share
$12.90
Trade value
$272.52K
% of position
0.5%
10/14/2021
3.89M→3.87M
Total
Net shares
−89.29K
Net value
-$1.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/7/2021 | S · Sale | −39.29K | $12.45 | $489.11K | 1.0% | 3.96M | 3.92M |
| Common Stock Direct | 10/12/2021 | S · Sale | −18K | $12.77 | $229.94K | 0.5% | 3.99M | 3.97M |
| Common Stock Direct | 10/13/2021 | S · Sale | −10.88K | $12.83 | $139.53K | 0.3% | 3.97M | 3.96M |
| Common Stock Direct | 10/14/2021 | S · Sale | −21.13K | $12.90 | $272.52K | 0.5% | 3.89M | 3.87M |
| Total | −89.29K | -$1.13M | ||||||
Derivative Transactions0
No derivative transactions reported